MRI as a Monitoring Tool for Detecting Therapeutic Response in the Recurrence of Carcinoma Cervix
DOI:
https://doi.org/10.64149/J.Carcinog.24.5s.717-720Keywords:
Cervix carcinoma, MRI, recurrenceAbstract
Background: Carcinoma cervix recurrence is difficult to assess clinically, and MRI offers superior soft tissue evaluation.
Methods: A hospital-based observational study was conducted on 44 post-treatment cases using T2W, DWI, and contrast MRI sequences. Clinical findings were correlated with imaging to determine diagnostic accuracy.
Results: MRI identified 22 recurrent lesions, including cases missed clinically. Sensitivity, specificity, and accuracy were 88.89%, 30%, and 57.89% respectively. The T2W+DWI combination diagnosed all recurrences and excluded false positives, while contrast had limited added value. MRI also detected nodal recurrence in one case without a pelvic mass.
Conclusion: MRI, especially T2W with DWI, is a reliable tool for post-treatment surveillance of carcinoma cervix, aiding early detection of recurrence and avoiding overtreatment.




